ECM
MRNA icon

Evergreen Capital Management’s Moderna MRNA Stock Holding History

Evergreen Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,080
Closed -$247K – 1040
2024
Q2 		$247K Buy
+2,080
New +$263K 0.01% 742
2023
Q1 		– Sell
-1,396
Closed -$251K – 744
2022
Q4 		$251K Buy
+1,396
New +$228K 0.01% 539

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Evergreen Capital Management's MRNA Position: Q3 2024 in Review

Evergreen Capital Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,080 shares — an estimated $247K sold.

Evergreen Capital Management first reported a position in MRNA in Q4 2022 and held it in 2 quarters. The position peaked at $251K in Q4 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Evergreen Capital Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Evergreen Capital Management sold 2,080 Moderna shares in Q3 2024, an estimated $247K.
  • Evergreen Capital Management first reported a position in Moderna in Q4 2022 and held it in 2 quarters.
  • Evergreen Capital Management's Moderna position peaked at $251K in Q4 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Evergreen Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.